Author:
Altunkaynak Yalçın,Yavuz Ömer,Levent Abdulkadir
Subject
Spectroscopy,Analytical Chemistry
Reference30 articles.
1. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus;DeFronzo;Banting Lecture,2009
2. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women;Hu;N. Engl. J. Med.,2001
3. Insulin action, diabetogenes, and the cause of type II diabetes;Kahn;Diabetes,1994
4. Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus;Neumiller;Pharmacotherapy,2010
5. B. Balas, M.R. Baig, C. Watson, B.E. Dunning, M. Ligueros-Saylan, Y. Wang, Y.L. He, C. Darland, J.J. Holst, C.F. Deacon, K. Cusi, A. Mari, J.E Foley. R.A. De Fronzo, The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients, J. Clin. Endocrinol. Metab. 92 (2007) 1249–1255. https://doi.org/10.1210/jc.2006-1882.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献